Form 4: SPX Technologies CEO Lowe Reports Equity Grants
Insider Transaction Report
SPX Technologies' President and CEO, Eugene Joseph Lowe III, reported the grant of restricted stock units and stock options, alongside a tax-related disposition of shares.
Summary
- Eugene Joseph Lowe III, President and CEO of SPX Technologies, Inc., was granted 19,536 restricted stock units (RSUs) on March 2, 2026, under the SPX 2019 Stock Compensation Plan.
- On March 3, 2026, 1,631 shares of common stock were delivered to the issuer for the payment of withholding taxes due upon the vesting of previously granted restricted stock units, at a price of $225.02 per share.
- A grant of 14,737 employee stock options was made on March 2, 2026, with an exercise price of $225.02 per share, pursuant to the SPX 2019 Stock Compensation Plan.
- Following these transactions, Mr. Lowe directly beneficially owns 819,700 shares of common stock, which includes unvested restricted stock units.
- Additionally, Mr. Lowe indirectly beneficially owns 5,047 shares of common stock through a 401(k) Plan.
- Mr. Lowe holds various other employee stock options with exercise prices ranging from $32.69 to $138.60, and expiration dates extending to March 3, 2035.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It reports routine executive compensation transactions (grants and tax-related dispositions) and does not contain information that would significantly alter the company's fundamental outlook or market perception.
Positives
- The grant of 19,536 restricted stock units and 14,737 employee stock options indicates continued equity-based compensation for the CEO, aligning management's interests with shareholder value creation.
Negatives
- The disposition of 1,631 shares for tax withholding, while a routine event upon RSU vesting, represents a reduction in direct share ownership.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that the reported transactions are routine executive compensation events, reflecting the grant of equity awards as part of the company's long-term incentive plan. Such grants are common practice across industries to align executive performance with shareholder returns.
Stakeholder Impact
- Shareholders: The equity grants align the CEO's financial interests with long-term shareholder value, as the value of these awards is tied to the company's stock performance.
- Employees: The filing details compensation for the CEO, which is part of the broader executive compensation structure, potentially influencing overall employee morale and retention strategies.
Next Steps
- The newly granted employee stock options will vest in three equal installments beginning on March 3, 2027.
Key Dates
| Date | Description |
|---|---|
| 02/22/2019 | Start of vesting for employee stock options granted on 02/22/2021. |
| 02/21/2020 | Start of vesting for employee stock options granted on 02/21/2022. |
| 02/20/2021 | Start of vesting for employee stock options granted on 02/20/2023. |
| 02/22/2021 | Grant date for 72,298 employee stock options with an exercise price of $32.69. |
| 03/01/2022 | Start of vesting for employee stock options granted on 03/01/2024. |
| 02/21/2022 | Grant date for 77,463 employee stock options with an exercise price of $36.51. |
| 03/01/2023 | Start of vesting for employee stock options granted on 03/01/2025. |
| 02/20/2023 | Grant date for 53,465 employee stock options with an exercise price of $50.09. |
| 03/01/2024 | Grant date for 46,291 employee stock options with an exercise price of $58.34. |
| 03/01/2024 | Start of vesting for employee stock options granted on 03/01/2026. |
| 02/28/2025 | Start of vesting for employee stock options granted on 02/28/2027. |
| 03/01/2025 | Grant date for 49,378 employee stock options with an exercise price of $48.97. |
| 03/02/2026 | Grant date for 19,536 restricted stock units and 14,737 employee stock options. |
| 03/01/2026 | Grant date for 33,707 employee stock options with an exercise price of $71.93. |
| 03/03/2026 | Date of disposition of 1,631 shares for tax withholding. |
| 03/03/2026 | Start of vesting for employee stock options granted on 03/03/2028. |
| 03/04/2026 | Signature date of the reporting person's attorney-in-fact. |
| 03/01/2027 | Expiration date for employee stock options granted on 03/01/2025. |
| 03/03/2027 | Start of vesting for employee stock options granted on 03/02/2026. |
| 02/28/2027 | Grant date for 24,238 employee stock options with an exercise price of $116.40. |
| 02/22/2028 | Expiration date for employee stock options granted on 02/22/2021. |
| 03/03/2028 | Grant date for 21,529 employee stock options with an exercise price of $138.60. |
| 02/21/2029 | Expiration date for employee stock options granted on 02/21/2022. |
| 03/02/2029 | Expiration date for employee stock options granted on 03/02/2026. |
| 02/20/2030 | Expiration date for employee stock options granted on 02/20/2023. |
| 03/01/2031 | Expiration date for employee stock options granted on 03/01/2024. |
| 03/01/2032 | Expiration date for employee stock options granted on 03/01/2025. |
| 03/01/2033 | Expiration date for employee stock options granted on 03/01/2026. |
| 02/28/2034 | Expiration date for employee stock options granted on 02/28/2027. |
| 03/03/2035 | Expiration date for employee stock options granted on 03/03/2028. |
| 03/02/2036 | Expiration date for employee stock options granted on 03/02/2026. |
Keywords
SPX Technologies, SPXC, Eugene Joseph Lowe III, Restricted Stock Units, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.